Disulfiram and copper for newly diagnosed brain cancer
Treatments studied
Part of Cancer clinical trials.
This study tests a drug called disulfiram (usually used for alcohol addiction) combined with copper, given after surgery for newly diagnosed glioblastoma. The goal is to see if this combination can help stop the cancer from growing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a new brain tumor called glioblastoma (stage IV) that can be mostly removed by surgery.
- You must be at least 18 years old and able to start the study drug on the fifth day after surgery.
- You must be generally healthy and able to take care of yourself (Karnofsky score of 70% or higher).
- Your blood counts and liver, kidney, and clotting functions must be within acceptable levels.
- You must not have other serious medical conditions, a history of alcoholism, or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a drug called disulfiram (commonly used for alcohol aversion) can help reduce immune suppression in the body and decrease the need for steroids in people with a high-grade brain tumor who are scheduled for surgery. Taking disulfiram before surgery may help the immune system fight the tumor better.
This trial tests whether adding a drug called mycophenolate mofetil to the standard treatment (radiation therapy and temozolomide) helps people with a newly diagnosed brain cancer called glioblastoma. The drug may boost the effect of the standard treatment.
This trial tests whether customized drug screening on your tumor cells can help doctors choose the best treatment for you. Your tumor cells will be grown in the lab and tested against different drugs to find what works best, combined with short-course radiation therapy.
This trial tests a combination of two drugs, bortezomib and temozolomide, for people whose brain tumor (glioblastoma) has returned after initial treatment. It's designed for tumors that don't respond well to standard treatments, and the goal is to see if this combination can help control the cancer.
This Phase 1/2 study tests whether “glutamate inhibitor” medications can be safely added for newly diagnosed glioblastoma, and how they affect treatment outcomes. It’s designed for adults who will also receive the standard chemo‑radiation plan with temozolomide.
This early-phase study tests whether liposomal curcumin, added to standard radiation plus temozolomide, can improve treatment outcomes in newly diagnosed high-grade gliomas. It focuses on safety and how well the treatment can be given with the usual therapy plan.
Hear when a new Glioblastoma Multiforme trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.